Kenneth A. Thomas

Statistics

Publications

Citations

9.2K

H-Index

Active since

1974

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Centro de Investigaciones Biológicas Margarita Salas

Kenneth A. Thomas is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, angiogenesis, and growth factor signaling.

Publications per year

1974–2006

Publications

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.

R.L. Kendall, Kenneth A. Thomas · Proceedings of the National Academy of Sciences · 1993 · 1.4K citations

Life Sciences, Molecular Biology, Cell Signaling +13

Identification of a Natural Soluble Form of the Vascular Endothelial Growth Factor Receptor, FLT-1, and Its Heterodimerization with KDR

Richard Kendall, Guan Wang, Kenneth A. Thomas · Biochemical and Biophysical Research Communications · 1996 · 727 citations

Life Sciences, Cell Biology, Molecular Medicine +8

Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate

Corey K. Goldman, Richard Kendall, Gustavo Cabrera et al. · Proceedings of the National Academy of Sciences · 1998 · 446 citations

Medicine, Cancer Biology, Oncology +16

Crystal structure of bovine Cu,Zn superoxide dismutase at 3 A resolution: chain tracing and metal ligands.

John F. Richardson, Kenneth A. Thomas, B. Rubin et al. · Proceedings of the National Academy of Sciences · 1975 · 404 citations · Full text

Life Sciences, Biochemistry, Biophysics +17

Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts.

Satoru Harada, Janice A. Nagy, Kathleen A. Sullivan et al. · Journal of Clinical Investigation · 1994 · 399 citations · Full text

Medicine, Developmental Biology, Molecular Biology +17

1–5 of 68